Making large quantities of this vaccine is faster than with traditional production methods because the basic cells are able to be frozen and stored, the company said in a statement.
The NIH said the scientists who developed these stem cells lines have told the agency that the stem cells are viable and can be frozen and cultured and have been through more than one population doubling.